Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?

Basit Öğe Kaydı
dc.authoridRonchi, Cristina/0000-0001-5020-2071
dc.authoridElhassan, Yasir/0000-0002-2735-6053
dc.contributor.authorSaygili, Emre Sedar
dc.contributor.authorElhassan, Yasir S.
dc.contributor.authorRonchi, Cristina L.
dc.date.accessioned2025-01-27T21:13:16Z
dc.date.available2025-01-27T21:13:16Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[Anstract Not Available]
dc.identifier.doi10.1016/S2589-7500(24)00019-0
dc.identifier.endpagee154
dc.identifier.issn2589-7500
dc.identifier.issue3
dc.identifier.pmid38395534
dc.identifier.scopus2-s2.0-85185797797
dc.identifier.scopusqualityQ1
dc.identifier.startpagee154
dc.identifier.urihttps://doi.org/10.1016/S2589-7500(24)00019-0
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28357
dc.identifier.volume6
dc.identifier.wosWOS:001200676200001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofLancet Digital Health
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.titleIs predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu